Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Birth Weight D001724 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Yamazaki H [Recent medical topics on platelets in hemorrhagic and thrombotic diseases]. 1986 Nippon Naika Gakkai Zasshi pmid:3027214
Lewis RE and Granger HJ Neutrophil-dependent mediation of microvascular permeability. 1986 Fed. Proc. pmid:3510911
DeFeudis FV Studies on endothelium-dependent vasorelaxation. 1986 Gen. Pharmacol. pmid:3512363
Ramesha CS and Pickett WC Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid. 1986 J. Biol. Chem. pmid:3011789
Vanhoutte PM et al. Modulation of vascular smooth muscle contraction by the endothelium. 1986 Annu. Rev. Physiol. pmid:2871807
Hellewell PG and Williams TJ A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin. 1986 J. Immunol. pmid:2940300
Handley DA et al. Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist. 1986 Immunopharmacology pmid:3019921
Hwang SB et al. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor. 1986 J. Biol. Chem. pmid:3020044
Biftu T et al. Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists. 1986 J. Med. Chem. pmid:3020247
Zanetti A et al. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine. 1986 Eur. J. Pharmacol. pmid:2944757
Bush LR and Smith SG Antagonism of U46619-induced aggregation of human and canine platelets by four TXA2 receptor antagonists. 1986 Thromb. Res. pmid:2948294
Valone FH and Ruis NM Platelet-activating factor binding to human platelet membranes. 1986 Biotechnol. Appl. Biochem. pmid:3021183
Naccache PH et al. Biochemical events associated with the stimulation of rabbit neutrophils by platelet-activating factor. 1986 J. Leukoc. Biol. pmid:3021882
Bourgain RH et al. Vivo effects of PAF-acether and arterial thrombosis. 1986 Adv. Exp. Med. Biol. pmid:3799334
Kloprogge E et al. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy. 1986 Biochem. J. pmid:3800968
Panchenko EP et al. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin]. 1986 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:3801147
Chamone DF et al. Increased levels of eosinophil-derived PAF-acether activity in a patient with idiopathic hypereosinophilic syndrome. 1986 Braz. J. Med. Biol. Res. pmid:3801724
Toth PD and Mikulaschek AW Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. 1986 Circ. Shock pmid:3802423
Hattori Y and Levi R Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. 1986 J. Pharmacol. Exp. Ther. pmid:3012066
Desquand S et al. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. 1986 Eur. J. Pharmacol. pmid:3019727
Weber N [A platelet-activating factor--a physiologically active ether lipid]. 1986 Pharm Unserer Zeit pmid:3749211
Page CP et al. Inflammatory mediators of asthma. 1986 Eur J Respir Dis Suppl pmid:3527737
Berti F et al. Cardiovascular and pulmonary activity of platelet-activating factor (PAF-acether) and its derivatives. 1986 Pharmacol Res Commun pmid:3749244
Mlczoch J [Disorders of thrombocyte function and/or endothelial cell damage as a cause of primary pulmonary hypertension?]. 1986 Herz pmid:3530927
Burhop KE et al. Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites. 1986 Am. Rev. Respir. Dis. pmid:3752711
Lovett DH and Sterzel RB Cell culture approaches to the analysis of glomerular inflammation. 1986 Kidney Int. pmid:3531678
Metz SA Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release. 1986 Diabetes pmid:3087803
Daniel LW et al. A novel mechanism of diglyceride formation. 12-O-tetradecanoylphorbol-13-acetate stimulates the cyclic breakdown and resynthesis of phosphatidylcholine. 1986 J. Biol. Chem. pmid:3087989
Malavasi F et al. Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3085094
Simpson AW et al. Low concentrations of the stable prostaglandin endoperoxide U44069 stimulate shape change in quin2-loaded platelets without a measurable increase in [Ca2+]i. 1986 FEBS Lett. pmid:3086128
Nakaya H and Tohse N Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine. 1986 Br. J. Pharmacol. pmid:3814909
Schlondorff D et al. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. 1986 Am. J. Physiol. pmid:3087218
Coëffier E et al. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs. 1986 Eur. J. Pharmacol. pmid:3816952
Schlondorff D and Neuwirth R Platelet-activating factor and the kidney. 1986 Am. J. Physiol. pmid:3089026
Oda M et al. Polymorphonuclear leukocyte-platelet interactions: acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide. 1986 J. Biochem. pmid:3818574
Nishihira J and Ishibashi T A phospholipase C with a high specificity for platelet-activating factor in rabbit liver light mitochondria. 1986 Lipids pmid:3821393
Lauri D et al. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. 1986 Agents Actions pmid:3706054
Nijssen JG et al. Identification of a calcium-independent phospholipase A2 in rat lung cytosol and differentiation from acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF-acether). 1986 Biochim. Biophys. Acta pmid:3707986
Fitzgerald MF et al. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs. 1986 Br. J. Pharmacol. pmid:3708213
Chand N et al. The amplifier role of platelet activating factor (PAF), other chemical mediators and antigen in the induction of airway hyperreactivity to cold. 1986 Eur. J. Pharmacol. pmid:3709669
Kloprogge E et al. Stimulus-aggregation coupling in platelets activated with PAF-acether. 1986 Biochim. Biophys. Acta pmid:3089297
Osborne JA et al. In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit. 1986 Res. Commun. Chem. Pathol. Pharmacol. pmid:3715198
Westwick J et al. Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro. 1986 Thromb. Res. pmid:3715810
Brock TA and Gimbrone MA Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells. 1986 Am. J. Physiol. pmid:3717361
Gillespie MN and Bowdy BD Impact of platelet activating factor on vascular responsiveness in isolated rat lungs. 1986 J. Pharmacol. Exp. Ther. pmid:3944767
Viero P et al. Thrombotic thrombocytopenic purpura and high-dose immunoglobulin treatment. 1986 Ann. Intern. Med. pmid:3946966
Siafaka-Kapadai A et al. Biological activity of lipids of pine pollen on platelet aggregation in correlation with the platelet activating factor. 1986 Biochem. Int. pmid:3947373
McNamara PJ et al. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG). 1986 Biochem. Pharmacol. pmid:3947392
Anderson RC et al. Platelet-activating factor analogs. II. Synthesis of the 1-O-(4-decyloxymethylphenyl)- and 1-O-(4-decyloxyphenylmethyl) analogs. 1986 Chem. Phys. Lipids pmid:3948294
Hwang SB et al. Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema. 1986 Eur. J. Pharmacol. pmid:3948914
Doyle VM et al. Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells. 1986 FEBS Lett. pmid:3949010
Wissner A et al. Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety. 1986 J. Med. Chem. pmid:3950913
Issekutz AC and Szpejda M Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988. 1986 Lab. Invest. pmid:3951199
Shukla SD Action of phosphatidylinositol specific phospholipase C on platelets: nonlytic release of acetylcholinesterase, effect on thrombin and PAF induced aggregation. 1986 Life Sci. pmid:3951330
Benveniste J Paf-acether (platelet-activating factor). 1986 Bull Eur Physiopathol Respir pmid:3955269
Phillips ML and Bonjouklian R Cyclic platelet-activating factor analogues derived from 2-deoxy-D-erythro-pentose. 1986 Carbohydr. Res. pmid:3955572
Becker EL et al. Pertussis toxin as a probe of neutrophil activation. 1986 Fed. Proc. pmid:3011523
Ozaki Y et al. Oxygen radical production by neutrophils from patients with bacterial infection and rheumatoid arthritis. Measurement of hydrogen peroxide may most accurately represent enhancement of oxygen radical production during infection. 1986 Inflammation pmid:3011666
Doebber TW et al. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. 1986 J. Immunol. pmid:3011900
McManus LM Pathobiology of platelet-activating factors. 1986 Pathol Immunopathol Res pmid:3543915
Tokumura A et al. Alkylacetylglycerophosphocholine effects on the metabolism of phospholipids in rabbit platelets: effects of extracellular Ca2+ and prostacyclin. 1986 Arch. Biochem. Biophys. pmid:3013094
Houslay MD et al. Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. 1986 Biochem. J. pmid:3013161
Davis RB and Johnson MF Effects of bacterial endotoxin and platelet activating factor (PAF) on human platelet aggregation in native whole blood. 1986 Thromb. Res. pmid:3544327
Fechter M et al. Experimental eosinophilia and inflammation--the effect of various inflammatory mediators and chemoattractants. 1986 Exp Pathol pmid:3013671
Fisher RA et al. Effects of beta-adrenergic stimulation on 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine-mediated vasoconstriction and glycogenolysis in the perfused rat liver. 1986 J. Biol. Chem. pmid:3013865
Patscheke H and Dierichs R Cationized ferritin as a platelet-stimulating surface probe. Binding to platelets and effects on platelet function. 1986 Eur. J. Cell Biol. pmid:3084260
Darius H et al. Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists. 1986 Int. Arch. Allergy Appl. Immunol. pmid:3015804
Billah MM et al. Metabolism of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human promyelocytic leukemic HL60 cells. Stimulated expression of phospholipase A2 and acetyltransferase requires differentiation. 1986 J. Biol. Chem. pmid:3084473
Kloprogge E et al. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets. 1986 J. Biol. Chem. pmid:3015954
Piper PJ and Stewart AG Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4. 1986 Br. J. Pharmacol. pmid:3091131
O'Flaherty JT et al. Binding and metabolism of platelet-activating factor by human neutrophils. 1986 J. Clin. Invest. pmid:3016027
Hanahan DJ Platelet activating factor: a biologically active phosphoglyceride. 1986 Annu. Rev. Biochem. pmid:3017194
Coëffier E et al. Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets. 1986 Br. J. Haematol. pmid:3964558
Raaijmakers JA et al. Phospholipase A2 products induce pulmonary beta-adrenoceptor deviations. 1986 Eur. J. Pharmacol. pmid:3019725
Ban C et al. Metabolism of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human fetal membranes and decidua vera. 1986 Arch. Biochem. Biophys. pmid:3963833
Bachelet M et al. Changes induced by PAF-acether in diacyl and ether phospholipids from guinea-pig alveolar macrophages. 1986 Biochim. Biophys. Acta pmid:3092866
Foegh ML et al. Fatty acids and eicosanoids in organ transplantation. 1986 Prog. Lipid Res. pmid:3321095
McKean ML et al. Formation of diacyl- and alkylacylphosphatidylcholine by the membranes of human platelets. 1986 FEBS Lett. pmid:3943622
Dewald B and Baggiolini M Platelet-activating factor as a stimulus of exocytosis in human neutrophils. 1986 Biochim. Biophys. Acta pmid:3017443
Ostermann G et al. Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues. 1986 Thromb. Res. pmid:3764811
Hsueh W et al. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. 1986 J. Clin. Invest. pmid:3459734
Rainsford KD Relative roles of leukotrienes and platelet activating factor in experimentally-induced gastric ulceration. 1986 Pharmacol Res Commun pmid:3774846
Page CP and Morley J Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma. 1986 Pharmacol Res Commun pmid:3774847
Thomas Y et al. [Synthesis of paf-acether by E. coli K12]. 1986 C. R. Acad. Sci. III, Sci. Vie pmid:3101984
Haye-Legrand I et al. Production of PAF-acether and leukotrienes by cultured mouse macrophages. 1986 Pharmacol Res Commun pmid:3774848
Küster LJ and Frölich JC Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man. 1986 Prostaglandins pmid:3097760
Dupont L et al. Crystal and molecular structure of BN 52021, a PAF-acether antagonist. Comparison with the conformation of Kadsurenone and related compounds. 1986 Pharmacol Res Commun pmid:3774849
Cordeiro RS et al. Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxygenase inhibitors are ineffective. 1986 Prostaglandins pmid:3103172
Bruynzeel PL et al. Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils. 1986 Pharmacol Res Commun pmid:3774850
Etienne A et al. The relative role of PAF-acether and icosanoids in septic shock. 1986 Pharmacol Res Commun pmid:3774851
Maes L et al. Endogenic PAF-acether production by guinea pig endothelial cells in experimental arterial thrombosis. 1986 Pharmacol Res Commun pmid:3774852
Handley DA et al. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441. 1986 Thromb. Haemost. pmid:3775689
Hwang SB and Lam MH Species difference in the specific receptors of platelet activating factor. 1986 Biochem. Pharmacol. pmid:3024653
Han GQ et al. [Neolignans from Piper hancei Maxim]. 1986 Yao Xue Xue Bao pmid:3776545
Koltai M et al. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. 1986 Eur. J. Pharmacol. pmid:3780855
Montrucchio G et al. Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist. 1986 Int J Tissue React pmid:3025124
Salari H Solid-phase extraction and reversed-phase high-performance liquid chromatographic technique for isolation and estimation of platelet activating factor in plasma. 1986 J. Chromatogr. pmid:3782417
Hwang SB et al. Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. 1986 J. Biol. Chem. pmid:3001070
Buxton DB et al. Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. 1986 J. Biol. Chem. pmid:3001074
Ng DS and Wong K GTP regulation of platelet-activating factor binding to human neutrophil membranes. 1986 Biochem. Biophys. Res. Commun. pmid:3026378